comprehensive -WSS

comprehensive

author：comprehensive 2025-10-01 02:13:00 - browse：235

Steven Pearson — ICER President Steven D. Pearson Craig F. Walker/The Boston Globe

Meetings of the Institute for Clinical and Economic Review don’t usually get one’s heart pumping. But a meeting Thursday at the Massachusetts Institute of Technology may prove to be the exception to that rule.

Patients Rising Now, an advocacy group that says it promotes transparency in health care and that is a fierce opponent of ICER’s, is expected to face off with the self-professed “watchdog of drug pricing” as it reviews three drugs for Duchenne muscular dystrophy.

Dozens of Duchenne patients and their families — many of whom also express concern that ICER’s review could undermine insurers’ already tepid interest in the treatments — are also expected to be in attendance.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Virginia high school admissions case could be legal follow
Next article： Transgender sports debate: Physicians say bans are health issue

WSS

BD to buy Edwards patient monitoring unit for $4.2 billion

Sutter Health’s antitrust win overturned by appeals court

Midwives could help bridge maternal health disparities in the U.S.

Patients, doctors press FTC to beef up hospital merger scrutiny

BD to buy Edwards patient monitoring unit for $4.2 billion

Fed up with FDA, ALS advocates consider a take

leisure time

comprehensive

knowledge

Alkermes shareholders re

Stopping antidepressants leads to symptoms for 1 in 6 patients

Peter Hotez and the public health issue of online harassment

FDA panel to weigh safety of artificial wombs for preterm births

Novavax promises a turnaround & Lilly roils the obesity market

Eli Lilly’s Zepbound improved liver scarring in mid

Apple is now the first public company to be valued at $3 trillion

CMS got Medicare Advantage quality rating wrong, judge rules

Psychedelics group wrestles with new pharma identity

Congress needs to close a vaccine

focus

FDA panel to weigh safety of artificial wombs for preterm births

Fed up with FDA, ALS advocates consider a take

White House Covid adviser calls on docs to combat misinformation

Sutter Health’s antitrust win overturned by appeals court

FDA panel to weigh safety of artificial wombs for preterm births

'A game

entertainment

Wikipedia

Wikipedia

hotspot